MedPath

Effect of tACS brain stimulation on inhibitory control of Alcohol Use Disorder patients

Phase 3
Conditions
Health Condition 1: H- Substance Abuse Treatment
Registration Number
CTRI/2024/07/070995
Lead Sponsor
Central Institute of Psychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Male patients diagnosed with Alcohol Dependence Syndrome as per International Classification of Disease - 10th revision - Diagnostic Criteria for Research.

Male with Alcohol Dependence aged between 18 to 50 years.

Severity of Alcohol Dependence Questionnaire (SADQ) in Male with Alcohol dependence greater than 16.

The Clinical Institute Withdrawal Assessment for Alcohol (revised version) in Male with Alcohol dependence CIWA-Ar lesser than or equal to 7.

Right-handed. Males with Alcohol dependence who are ready to give informed consent.

Exclusion Criteria

Male with Alcohol dependence having any other co-morbid substance dependence.

Male with Alcohol dependence having any medical illness.

Male with Alcohol dependence having any other psychiatric illness, dementia, psychotic disorder.

Male with Alcohol dependence who are on any psychotropic medication in 2 weeks preceding and during the study.

Male with Alcohol dependence who have received ECT in past 6 months.

Colour blind. Male with Alcohol dependence having any metallic implants/parts in the body.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effectiveness of Alpha tACS on inhibitory control in patients with alcohol use disordersTimepoint: Baseline, 5 days
Secondary Outcome Measures
NameTimeMethod
fMRI activation of ACC using Alcoholic Go/No Go task in patients of Alcohol Use DisordersTimepoint: Baseline, 5 days
© Copyright 2025. All Rights Reserved by MedPath